These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9453275)

  • 1. Frequency of severe attacks in migraine sufferers of the Gazel cohort.
    Michel P; Dubroca B; Dartigues JF; El Hasnaoui A; Henry P
    Cephalalgia; 1997 Dec; 17(8):863-6. PubMed ID: 9453275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.
    Stewart WF; Lipton RB; Celentano DD; Reed ML
    JAMA; 1992 Jan; 267(1):64-9. PubMed ID: 1727198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pivotal moment in 50 years of headache history: the first American Migraine Study.
    Tepper SJ
    Headache; 2008 May; 48(5):730-1; discussion 732. PubMed ID: 18471125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden.
    Linde M; Dahlöf C
    Cephalalgia; 2004 Jun; 24(6):455-65. PubMed ID: 15154855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapatient variability of migraine attacks: stability analysis of the MIGSEV scale.
    Baha M; Nachit-Ouinekh F; El Hasnaoui A
    Headache; 2008 Jan; 48(1):79-85. PubMed ID: 18184289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year prevalence of migraine in Sweden: a population-based study in adults.
    Dahlöf C; Linde M
    Cephalalgia; 2001 Jul; 21(6):664-71. PubMed ID: 11531898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM.
    Henry P; Michel P; Brochet B; Dartigues JF; Tison S; Salamon R
    Cephalalgia; 1992 Aug; 12(4):229-37; discussion 186. PubMed ID: 1525798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FRAMIG 2000: medical and therapeutic management of migraine in France.
    Lucas C; Chaffaut C; Artaz MA; Lantéri-Minet M
    Cephalalgia; 2005 Apr; 25(4):267-79. PubMed ID: 15773824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictability of future attacks by migraineurs: a prospective observational study.
    Hu XH; Golden W; Bolge SC; Katic B; Chen YT; Wagner S; Cady R
    Headache; 2010 Sep; 50(8):1296-305. PubMed ID: 20236350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
    Meadows KP; Pierce M; O'Neill C; Foster S; Jennings C
    Headache; 2014 May; 54(5):850-60. PubMed ID: 24708392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing migraine disability by diary-based measurement: relationship to the characteristics of individual headache attacks.
    Park JW; Shin HE; Kim JS; Lee KS
    Eur J Neurol; 2008 Aug; 15(8):817-21. PubMed ID: 18549394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration.
    Stewart WF; Shechter A; Lipton RB
    Neurology; 1994 Jun; 44(6 Suppl 4):S24-39. PubMed ID: 8008223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of migraine to the individual sufferer: a review.
    Dahlof CG; Solomon GD
    Eur J Neurol; 1998 Nov; 5(6):525-533. PubMed ID: 10210887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.
    Lucas C; Géraud G; Valade D; Chautard MH; Lantéri-Minet M
    Headache; 2006 May; 46(5):715-25. PubMed ID: 16643573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
    MacGregor EA; Brandes J; Eikermann A; Giammarco R
    Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of migraine triggers in a clinic-based population.
    Andress-Rothrock D; King W; Rothrock J
    Headache; 2010 Sep; 50(8):1366-70. PubMed ID: 21044280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine.
    Goldstein J; Hoffman HD; Armellino JJ; Battikha JP; Hamelsky SW; Couch J; Blumenthal H; Lipton RB
    Cephalalgia; 1999 Sep; 19(7):684-91. PubMed ID: 10524663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible precipitation of migraine attacks with prophylactic treatment.
    Donnet A; Vuillaume De Diego E; Lanteri-Minet M
    Eur Neurol; 2009; 61(1):23-6. PubMed ID: 18948696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.